The Valley Desk

NCT00074854 · Interventional trial

A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy

Overall registry status Completed

Phase 1 · Phase 2

Conditions Lung Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov